Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Breast cancer
View:
Post by scarlet1967 on Feb 03, 2021 12:26pm

Breast cancer

Spartrap just posted this research study from university of Gothenburg in Sweden published recently.
Read page 40!
https://gupea.ub.gu.se/bitstream/2077/66821/2/gupea_2077_66821_2.pdf
Comment by scarlet1967 on Feb 03, 2021 12:27pm
https://stocktwits.com/Spartrap/message/283183986  
Comment by qwerty22 on Feb 03, 2021 12:52pm
It really doesn't take much to show if THTX's drug has an inhibitory effect of this progranulin/sortilin mechanism. Basically all you need to do is repeat the expt the Swede's did but replace the sortilin inhibitor with THTTX's drug and see if you get the same outcome, maybe throw in a few more controls as well like THTX's peptide-alone and docetaxel-alone but you get an answer ...more  
Comment by scarlet1967 on Feb 03, 2021 1:09pm
“Progranulin and one of its signaling receptors sortilin have previously been shown to be involved in cancer stem cell propagation and in metastasis formation. Taken together, these results demonstrated that progranulin increased cell secretion of many proteins, several of them dependent on sortilin binding. It has previously been shown that progranulin increase metastasis formation via sortilin ...more  
Comment by qwerty22 on Feb 03, 2021 2:03pm
It's proving the drug actually interferes with that process is what is required.
Comment by scarlet1967 on Feb 03, 2021 2:09pm
Yes I sent it to Leah...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities